MedMira is committed to creating lasting value for all stakeholders. Our Corporate Governance principles provide the foundation for this commitment by guiding our business activities toward sustainable value creation and continuous innovation. They also define a management culture that aligns with recognised standards of good corporate governance and ensures transparent, reliable communication.
Board composition
Steering rapid testing into the future
Corporate governance at MedMira ensures responsible oversight, transparency, and long-term value creation. With a Whole Board led by a majority of independent directors, we unite broad industry experience with clear, accountable decision-making. Together, we provide the governance that drive the future of rapid testing.
Our Board composition is shown belos, with director details available.
Chair member of the Audit Committee, Nomination and Compensation Committee
Member of the Audit Committee, Nomination and Compensation Committee
Executive Leadership
At MedMira, innovation, collaboration, and uncompromising accuracy define our work.
Our executive team is committed to advancing rapid tests that deliver qualitative and quantitative results, drive research, enable earlier diagnosis, and support targeted patient management.
Co-Founder & Co-Inventor
BioScience Innovator of the Year by The Economist in 2007
Worked in medical device industry in Africa, Asia Pacific, and Europe
+25 years of experience in Finance & Business development
Contacts Investor Relations
For more information about MedMira or inquiries related to Investor Relations, please contact us. Our Investor relations team will get back to you immediately.
Corporate Headquarters
155 Chain Lake Drive, Suite 1
Halifax, Nova Scotia B3S 1B3
Canada
Phone: 902 450 1588
T/F. 877 633 6372
E-Mail: ir@medmira.com